Imperial College London


Faculty of MedicineDepartment of Immunology and Inflammation

Professor of Practice (Chronic Myeloid Malignancies)



+44 (0)20 3313 5038d.milojkovic




Cancer CentreHammersmith Campus






Cook L, O'dell G, Vourvou E, et al., 2022, Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies, Nature Communications, Vol:13, ISSN:2041-1723, Pages:1-6

Innes AJ, Mullish BH, Ghani R, et al., 2021, Fecal microbiota transplant mitigates adverse outcomes in patients colonized with multidrug-resistant organisms undergoing allogeneic hematopoietic cell transplantation, Frontiers in Cellular and Infection Microbiology, Vol:11, ISSN:2235-2988, Pages:1-8

Maynard S, Ros-Soto J, Chaidos A, et al., 2021, The role of ibrutinib in COVID-19 hyperinflammation: a case report, International Journal of Infectious Diseases, Vol:105, ISSN:1201-9712, Pages:274-276

Pavlu J, Auner H, Szydlo RM, et al., 2017, Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservation., Bone Marrow Transplantation, Vol:52, ISSN:1476-5365, Pages:1599-1601

Claudiani S, Apperley JF, Deplano S, et al., 2016, Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia, American Journal of Hematology, Vol:91, ISSN:1096-8652, Pages:E480-E481

More Publications